INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
INJECTION
INTERVIEW
Dr Alexandre Fontayne
Unither Pharmaceuticals
Interview with Alexandre Fontayne, Unither Pharmaceuticals
Guy Furness and Alexandre Fontayne discusses Unither Pharmaceuticals' EuroJect
®
injection device, based on the company’s extensive experience with blow-fill-seal technology. Mr Fontayne covers the advantages of EuroJect
®
compared with traditional glass syringes and multidose vials, as well as touching on where Unither sees EuroJect
®
having an impact in the market
FORMULATION
Asmita Khanolkar
SMC Ltd
AN ENABLING AUTOINJECTOR TECHNOLOGY FOR DELIVERY OF LONG-ACTING INJECTABLES
Asmita Khanolkar and Susanna White explain why SMC Ltd's Vita autoinjector with resuspension technology provides a potential solution for the delivery challenges of long-acting injectables.
PREFILLED SYRINGES
Dr Laura Berardi
Stevanato Group
STAINLESS STEEL NEEDLES: QUANTIFYING COBALT RISK TO COMPLY WITH EU MEDICAL DEVICE REGULATION
Laura Berardi discusses the reclassification of cobalt as a Category 1B carcinogen and presents a series of analytical studies into the toxicological risk present in needles and complete syringes.
PREFILLED SYRINGES
Shiva Douse
Celanese
SANTOPRENE
®
TPV – A NEXT STEP IN ELASTOMERIC COMPONENTS FOR CONVENTIONAL, SAFETY AND PREFILLED SYRINGES AND AUTOINJECTORS
Shiva Douse, Jeff Smith and Brad Wessman introduce Santoprene® TPV, a novel medical-grade thermoplastic elastomer for use in syringes and autoinjectors that offers significant benefits over traditional thermoset rubbers.
PREFILLED SYRINGES
Tom Van Ginneken
SCHOTT Pharma
DELIVERY SOLUTIONS FOR DEEP-COLD DRUGS
Tom Van Ginneken considers how the growing pipeline of molecules that require cold storage has highlighted the need for better drug containment and delivery methods and highlights the potential SCHOTT TOPPAC
®
freeze syringes offer as a potential solution.
INJECTION
Hiroki Hasegawa
Mitsubishi Gas Chemical
CONTAINER CLOSURE INTEGRITY OF OXYCAPT™ VIAL AT -80°C WITH DRY ICE
Hiroki Hasegawa and Tomohiro Suzuki highlight the overall benefits of OXYCAPT, Mitsubishi Gas Chemical’s multilayer plastic vial, as a primary container for biologics and gene and cell therapies and discuss the company’s recent investigation into OXYCAPT’s performance at -80°C under dry ice conditions.
SUSTAINABILITY
Alex Fong
Owen Mumford
PRACTICAL PATHWAYS TO SUSTAINABILITY
Alex Fong and Olivia Houselander discuss the importance of sustainability in the healthcare sector and the challenges that must be overcome to achieve it in a meaningful and lasting way.
DUAL CHAMBER
Dr Brent Buchine
Windgap Medical
DESIGNING FOR SUCCESS: CHOOSING THE RIGHT PRIMARY DRUG CONTAINER FOR PREFILLED DELIVERY DEVICES
Brent Buchine and Jason Durkin reflect on the motivations and lessons from Windgap’s journey to design patient-centric, prefilled autoinjectors around custom and standard primary drug containers.
EARLY INSIGHT
Dr Phil Green
Capa Valve
CAPA VALVE’S PATENTED TECHNOLOGY TRANSFORMS ANY SYRINGE INTO A DCD
Phil Green, Dale Charlton and Kevin Abbott introduce Capa Valve’s novel valve system for converting standard syringes into prefilled dual-chamber devices, capable of simplifying and improving the delivery of liquid-liquid and liquid-powder drug products, including reconstitution of lyophilised powders.
WEARABLES
Omar Rahman
Enable Injections
BEYOND THE POINT: NAVIGATING THE IMPACT OF NEEDLES ON PAIN, ANXIETY AND THE PATIENT EXPERIENCE
Omar Rahman, Mehul Desai and Keith Candiotti discuss the role that needle size plays in the pain and anxiety patients experience during injections and how smaller, hidden needles (30G), such as those employed by Enable Injections’ enFuse large-volume injector, may minimise patient discomfort and maximise subcutaneous injection efficiency.
EXPERT VIEW
Kamaal de Silva
FROM CONCEPT TO CURE: MASTERING LIQUID SILICONE RUBBER FOR MEDICAL DEVICE DESIGN
Kamaal de Silva discusses the potential value of liquid silicone rubber in medical device design, including how its processing differs from other elastomers and how the challenges involved in its design and implementation can be overcome with specialist knowledge and experience.
PREFILLED SYRINGES
Alastair Willoughby
Team Consulting
DISCUSSION PRIMER: PHARMAPACK
Pharmapack’s organisers spoke with three industry experts, Alastair Willoughby, Jamie Greenwood and Chris Hurlstone, all from Team Consulting, to get their perspectives on the major trends expected to be top discussion topics at the event, and to play a significant role in the industry throughout 2024 and beyond.
INJECTION
Bill Welch
PCI Pharma Services
KEY CONSIDERATIONS FOR SUCCESSFUL COMMERCIALISATION OF DRUG-DEVICE COMBINATION PRODUCTS
Bill Welch delves into the key considerations that stakeholders must address to ensure the successful commercialisation of drug-device combination products.
EARLY INSIGHT
John Palmer-Felgate
Eco-inject
AN ECO-FRIENDLY AND ECONOMICAL APPROACH TO AUTOINJECTORS
John Palmer-Felgate introduces Eco-inject's patented innovation – a single-use, two-step autoinjector that is both eco-friendly and economical.
WEARABLES
Dr Hong-Jun Yeh
MicroMED Co Ltd
ADVANCING SUBCUTANEOUS DELIVERY OF BIOLOGICS: A NOVEL REUSABLE MEMS-ENABLED ACTUATOR
Hong-Jun Yeh, Jiunn-Ru Lai and Tsung-Chieh Cheng explore the challenges and opportunities related to the subcutaneous delivery of biotherapeutics. They also highlight a novel reusable MEMS-enabled pneumatic actuation system designed to overcome these challenges.
INTERVIEW
Dr Troels Keldmann
A SYMBIOTIC RELATIONSHIP BETWEEN DRUG DELIVERY DEVICE SYSTEMS AND PHARMA
Troels Keldmann discusses the significance of the drug delivery industry, its relationship to pharma, the challenges it faces and how the pharma industry is shaping the drug delivery device field.
CONNECTIVITY
Michael Earl
Owen Mumford
CONQUERING THE CHALLENGES OF CONNECTED DRUG DELIVERY DEVICE DEVELOPMENT
Michael Earl discusses the factors that need to be taken into account for successful connected drug delivery device development.
CONNECTIVITY
Joachim Koerner
Aptar Digital Health
IMPROVING MEDICATION ADHERENCE AND CLINICAL OUTCOMES THROUGH CONNECTED DRUG DELIVERY DEVICES
Joachim Koerner and Marcus Bates discuss the challenge that medication non-adherence presents to the healthcare sector, and the potential value of connected digital health solutions as a way of overcoming this challenge.
EXPERT VIEW
Paul Draper
UNLOCKING THE POTENTIAL OF CONNECTED DRUG DELIVERY DEVICES FOR DIABETES
Paul Draper discusses the current state of connected injection pens and devices in the diabetes space, exploring the benefits that connectivity can bring to drug delivery devices and considering how to exemplify good design in a connected injection device for diabetes drug therapies.
CONNECTIVITY
Pascal Dugand
Nemera
HOW TO NAVIGATE A COMPLEX CONNECTIVITY ENVIRONMENT
Pascal Dugand, Cécile Gross and Mark Tunkel consider the complexity of the landscape for connected devices and demonstrate how a balance can be achieved between patient needs, technology and the cost of integrating this technology into a device.
SUSTAINABILITY
Henryk Badack
Vetter Pharma
TIPS AND TRICKS FOR IMPLEMENTING SUSTAINABILITY INITIATIVES
Henryk Badack outlines Vetter's efforts to establish sustainable business practices.
SUSTAINABILITY
Dr Bettine Boltres
West Pharmaceutical Services
THE EVOLUTION OF THE PHARMA ECOSYSTEM: PRODUCT PERFORMANCE NOW MEETS SUSTAINABILITY
Bettine Boltres and Shivani Polasani discuss how pharma can progress towards a more sustainable future, and consider the role that the collaboration between Corning and West Pharmaceutical Services can play in supporting pharma’s sustainability goals.
EXPERT VIEW
Paramesh Natarajan
HOW LIFECYCLE ASSESSMENT SUPPORTS INSIGHT-DRIVEN SUSTAINABLE DESIGN
Paramesh Natarajan, Shadi Bavar and Charlie Dean present the case for using screening lifecycle assessments to lead into more detailed targeted and comprehensive lifecycle assessments focused on the areas of greatest environmental impact, using a screening lifecycle assessment of a hypothetical body-worn injector as an example.
INDUSTRIALISATION
Edwin Hendrawan
SHL Medical
AN AUTOINJECTOR REVOLUTION: ADVANCED SIMULATION TECHNOLOGIES ENHANCING GLOBAL MANUFACTURING NETWORKS
Edwin Hendrawan, Yi-Chi Lu and Christian Walter set out how SHL is building simulation capabilities, and describe how simulation will propel the business forward on every level, from individual shop floors to overall global expansion planning, in order to be able to meet the growing and increasingly complex demands from both pharma customers and patients.
Prev
1
…
9
10
11
12
13
…
44
Next
Top
